Table 2.
Overview of surveys and schedule of data collection for the Transforming Health and Reducing Perinatal Anxiety through Virtual Engagement (THRIVE) phase I randomized clinical trial
| Instrumentation | Time point | ||||||
| Measure | Validated for use in pregnancy | Screening | Enrollment | 3 weeks+/- 1 week | 6 weeks+/- 1 week | 10 weeks+/- 1 week | 7 weeks after delivery+/- 1 week |
| Demographics | —a | ✓ | ✓ |
|
|
|
✓ |
| Pregnancy outcome and history | — |
|
✓ |
|
|
|
|
| Pregnancy health | — | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Care and social support | — |
|
✓ | ✓ | ✓ | ✓ | ✓ |
| Labor and delivery experience | — |
|
|
|
|
|
✓ |
| Infant health and wellbeing | — |
|
|
|
|
|
✓ |
| GAD-7b | Yes | ✓ |
|
✓ | ✓ | ✓ | ✓ |
| PSS-4c | Yes |
|
✓ | ✓ | ✓ | ✓ | ✓ |
| PRASd | Yes |
|
✓ | ✓ | ✓ | ✓ |
|
| ISIe | Yes |
|
✓ | ✓ | ✓ | ✓ | ✓ |
| PHQ-9f | Yes |
|
✓ | ✓ | ✓ | ✓ | ✓ |
aNot applicable.
bGAD-7: Generalized Anxiety Disorder 7 Scale.
cPSS-4: Perceived Stress Scale 4.
dPRAS: Pregnancy Related Anxiety Scale.
eISI: Insomnia Severity Index.
fPHQ-9: Patient Health Questionnaire-9.